MRK vs BMY
Merck & Co. vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | MRK | BMY |
|---|---|---|
| AI Score | 56 | 60 |
| Price | $123.48 | $57.56 |
| P/E Ratio | 34.71× | 19.93× |
| ROE | 17.9% | 41.6% |
| Revenue Growth YoY | 2.9% | 1.8% |
| Gross Margin | 78.1% | 53.7% |
| Debt / Equity | 0.94× | 2.44× |
| Dividend Yield | 2.7% | 4.3% |
| RSI (14) | 45.9 | 53.8 |
| Beta | 0.21 | 0.235 |
| Expected Upside | +0.4% | +4.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MRK Full Analysis
BMY Full Analysis